© Copyright GW Pharmaceuticals 2021
This website is intended for healthcare professionals only. If you are not a healthcare professional, please visit www.gwpharm.co.uk
VV-MED-19197
Date of Preparation: March 2021
A faculty of global experts
The webcasts will bring together a faculty of global experts who have used GW CBD in the treatment of Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS).
-
Prof. Dr.
Selim Benbadis -
Prof. Dr.
Ulrich Brandl -
Prof. Dr.
Richard FM Chin -
Prof. Dr.
Angela M Kaindl -
Prof. Dr.
Andreas Schulze-Bonhage -
Prof. Dr.
Bernhard Steinhoff -
Prof. Dr.
Elizabeth Thiele -
Prof. Dr.
Sameer M Zuberi -
PhD
Nick Jones
Selim Benbadis
- Prof. Dr.
- USA
- University of South Florida
Selim Benbadis is Professor of Neurology at the University of South Florida and is Director of the University of South Florida/Tampa General Hospital Comprehensive Epilepsy Program. He has authored more than 100 articles and book chapters and serves on several editorial boards.
Ulrich Brandl
- Prof. Dr.
- Germany
- University Hospital Jena
Ulrich Brandl is Director of the Department of Neuropaediatrics, University Hospital Jena, Germany, where he also serves as Chairman of the Ethics Committee.
Richard FM Chin
- Prof. Dr.
- United Kingdom
- Royal Hospital for Sick Children, Edinburgh
Richard Chin is Professor of Paediatric Neurology and Clinical Epidemiology, and the Director of the Muir Maxwell Epilepsy Centre, at The University of Edinburgh, UK. He is an Honorary Consultant Paediatric Neurologist at the Royal Hospital for Sick Children (Edinburgh).
Angela M Kaindl
- Prof. Dr.
- Germany
- Charité – Universitätsmedizin Berlin
Angela Kaindl is Director of the Department of Pediatric Neurology and the Center for Chronically Sick Children at Charité – Universitätsmedizin Berlin. She is also Principal Investigator at the Charité Institute of Cell Biology and Neurobiology.
Andreas Schulze-Bonhage
- Prof. Dr.
- Germany
- Epilepsy Center, University Hospital Freiburg
Andreas Schulze-Bonhage is Medical Director at the Freiburg Epilepsy Center, University of Freiburg, and President of the German Society of Epileptology. He is author of more than 340 peer-reviewed publications, has been active as a Principal Investigator in 40 multicentre clinical trials, and receives research funding from the EU, German Federal Ministry of Education and Research (BMBF), Deutsche Forschungsgemeinschaft, and the National Institutes of Health.
Bernhard Steinhoff
- Prof. Dr.
- Germany
- Kork Epilepsy Centre and University of Freiburg
Bernhard Steinhoff is Professor of Neurology and Clinical Neurophysiology at the University of Freiburg and is Medical Director of the Epilepsy Centre Kork. He is a past president of the German Society of Epileptology and author of numerous peer-reviewed papers and book articles.
Elizabeth Thiele
- Prof. Dr.
- USA
- Massachusetts General Hospital
Elizabeth Thiele is Director of the Pediatric Epilepsy Service at Massachusetts General Hospital, Boston, MA, USA, and is Professor of Neurology at the Harvard Medical School. She organised and established the Herscot Center for Tuberous Sclerosis Complex and a ketogenic diet clinic to treat and manage patients with epilepsy.
Sameer M Zuberi
- Prof. Dr.
- United Kingdom
- Royal Hospital for Children, Glasgow
Sameer Zuberi is Consultant Paediatric Neurologist at the Royal Hospital for Children and Honorary Professor of Paediatric Neurology in the University of Glasgow. He leads the Paediatric Neurosciences Research Group and is clinical lead of the Scottish National Genetic Epilepsy Service. His other roles include President of the European Paediatric Neurology Society, Editor-in-Chief of the European Journal of Paediatric Neurology, past Chair of the International League Against Epilepsy (ILAE) Commission on Classification & Terminology (2013-17) and ILAE Nosology & Definitions Task Force Member.
Nick Jones
- PhD
- United Kingdom
- GW Pharmaceuticals Ltd
Nick Jones is Director of Regulatory Affairs at GW Pharmaceuticals Ltd and has 13 years of cannabinoid experience, including a GW-funded PhD in the field of pharmacology elucidating the non-clinical anticonvulsant potential of CBD for the treatment of epilepsies. Nick transitioned to Global Regulatory Affairs after 8 years in the Preclinical Department at GW directing development programmes and overseeing operations.
Faculty Disclosures
Selim Benbadis
- Consultant for Brain Sentinel, Cavion, Ceribell, Eisai, Greenwich, LivaNova, NeuroPace, SK Biopharmaceuticals, Sunovion
- Speakers’ bureau for Eisai, Greenwich, LivaNova, Sunovion
- National Medical Director for RSC Diagnostic Services (EEG)
- Florida Medical Director of Stratus/Alliance (EEG)
- Member of Epilepsy Study Consortium
- Grant support from Cavion, LivaNova, Greenwich, SK Biopharmaceuticals, Sunovion, Takeda, Xenon
- Royalties as an author or editor for eMedicine-Medscape-WebMD, UpToDate
- Editorial board for Epilepsy.com (Epilepsy Foundation) controversy section, eMedicine-Medscape-WebMD, Epileptic Disorders, Epilepsy and Behavior, Expert Review of Neurotherapeutics
Ulrich Brandl
- Honoraria for presentations, lectures, or advisory boards from Bial, Desitin, Eisai, GW Pharmaceuticals, UCB, Zogenix
Richard FM Chin
- Honoraria for presentations, lectures, or advisory boards from GW Pharmaceuticals, Zogenix, Eisei
- Local principal investigator in GW Pharmaceuticals and Zogenix sponsored clinical trials
- GW Pharmaceuticals has provided Epidyolex® free of charge for patients on a named patient basis
Angela M Kaindl
- Speaker honoraria from GW Pharmaceuticals
Andreas Schulze-Bonhage
- Research support from Bial, BMBF, DFG, EU, HBP, NIH
- Honoraria for lectures or advice from Arvelle, Bial, Eisai, GW Pharmaceuticals, UCB
Bernhard Steinhoff
- Speaker honoraria from Al-Jazeera, Desitin, Eisai, GW Pharmaceuticals, Hikma, Novartis, Sandoz, UCB
- Advisory boards or consultancy agreements from Arvelle, Bial, B. Braun, Desitin, Eisai, GW Pharmaceuticals, UCB
Elizabeth Thiele
- Consultant for GW Pharmaceuticals, Zogenix, Biocodex, Aquestive, West Therapeutics, RegenexBio
- Research grants from GW Pharmaceuticals, Zogenix
Sameer M Zuberi
- Research funding from Epilepsy Research UK, Glasgow Childrens Hospital Charity, UCB Pharma, Dravet Syndrome UK, Ring Chromosome 20 Research & Support, Tenovus Foundation
- Honoraria for advisory boards, educational activities and consultancy for GW Pharmaceuticals, Zogenix Ltd, Biocodex, Encoded Genomics, UCB Pharma, Nutricia
- Principal investigator on behalf of his institution for commercial research trials for GW Pharmaceuticals and Zogenix Ltd
Nick Jones
Full-time employee of GW Pharmaceuticals
